Cancer and fertility preservation: international recommendations from an expert meeting

In the last years, thanks to the improvement in the prognosis of cancer patients, a growing attention has been given to the fertility issues. International guidelines on fertility preservation in cancer patients recommend that physicians discuss, as early as possible, with all patients of reproductive age their risk of infertility from the disease and/or treatment and their interest in having children after cancer, and help with informed fertility preservation decisions. As recommended by the American Society of Clinical Oncology and the European Society for Medical Oncology, sperm cryopreservation and embryo/oocyte cryopreservation are standard strategies for fertility preservations in male and female patients, respectively; other strategies (e.g. pharmacological protection of the gonads and gonadal tissue cryopreservation) are considered experimental techniques. However, since then, new data have become available, and several issues in this field are still controversial and should be addressed by both patients and their treating physicians.In April 2015, physicians with expertise in the field of fertility preservation in cancer patients from several European countries were invited in Genova (Italy) to participate in a workshop on the topic of “cancer and fertility preservation”. A total of ten controversial issues were discussed at the conference. Experts were asked to present an up-to-date review of the literature published on these topics and the presentation of own unpublished data was encouraged. On the basis of the data presented, as well as the expertise of the invited speakers, a total of ten recommendations were discussed and prepared with the aim to help physicians in counseling their young patients interested in fertility preservation.Although there is a great interest in this field, due to the lack of large prospective cohort studies and randomized trials on these topics, the level of evidence is not higher than 3 for most of the recommendations highlighting the need of further research efforts in many areas of this field. The participation to the ongoing registries and prospective studies is crucial to acquire more robust information in order to provide evidence-based recommendations.

[1]  A. Pellicer,et al.  Obstetric outcome after oocyte vitrification and warming for fertility preservation in women with cancer. , 2014, Reproductive biomedicine online.

[2]  T. Fornander,et al.  Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial , 2009, Breast Cancer Research and Treatment.

[3]  A. Loft,et al.  Cryopreservation of ovarian tissue for a decade in Denmark: a view of the technique. , 2011, Reproductive biomedicine online.

[4]  Satyaki Sengupta,et al.  Chemotherapy-Induced Late Transgenerational Effects in Mice , 2011, PloS one.

[5]  J. Raemaekers,et al.  Premature ovarian failure and fertility in long-term survivors of Hodgkin's lymphoma: a European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Etude des Lymphomes de l'Adulte Cohort Study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  A. Giwercman,et al.  Risk of Birth Abnormalities in the Offspring of Men With a History of Cancer: A Cohort Study Using Danish and Swedish National Registries , 2011, Journal of the National Cancer Institute.

[7]  M. Rezai,et al.  Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  S. Kim,et al.  Use of Hormonal Protection for Chemotherapy-induced Gonadotoxicity , 2010, Clinical obstetrics and gynecology.

[9]  P. Patrizio,et al.  Human oocyte cryopreservation with slow freezing versus vitrification. Results from the National Italian Registry data, 2007-2011. , 2014, Fertility and sterility.

[10]  G. Hortobagyi,et al.  Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients , 1990, Cancer.

[11]  Anna Carby,et al.  Reproductive options for female cancer patients: balancing hope and realistic expectation , 2014, Current opinion in oncology.

[12]  Amul Shah,et al.  Results from the survey for preservation of adolescent reproduction (SPARE) study: gender disparity in delivery of fertility preservation message to adolescents with cancer , 2011, Journal of Assisted Reproduction and Genetics.

[13]  N. Pavlidis,et al.  Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. , 2011, European journal of cancer.

[14]  S. Fosså,et al.  Paternity following treatment for testicular cancer. , 2005, Journal of the National Cancer Institute.

[15]  C. Andersen,et al.  The safety of transplanting cryopreserved ovarian tissue in cancer patients: a review of the literature , 2012, Journal of Assisted Reproduction and Genetics.

[16]  H. Bang,et al.  Age-specific probability of live birth with oocyte cryopreservation: an individual patient data meta-analysis. , 2013, Fertility and sterility.

[17]  W. Wallace,et al.  Predicting age of ovarian failure after radiation to a field that includes the ovaries. , 2005, International journal of radiation oncology, biology, physics.

[18]  J. Pierce,et al.  How do you feel about fertility and parenthood? The voices of young female cancer survivors , 2012, Journal of Cancer Survivorship.

[19]  K. Oktay,et al.  Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles. , 2011, Fertility and sterility.

[20]  S. Willich,et al.  Patient Counselling on the Risk of Infertility and Its Impact on Childhood Cancer Survivors: Results from a National Survey , 2011, Journal of psychosocial oncology.

[21]  Y. Englert,et al.  Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  N. Desai,et al.  Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis. , 2010, Fertility and sterility.

[23]  K. Oktay,et al.  In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation. , 2008, Fertility and sterility.

[24]  W. Wallace,et al.  Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults. , 2015, The lancet. Diabetes & endocrinology.

[25]  S. Loh,et al.  First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient. , 2014, Human reproduction.

[26]  R. Rosenfeld Patients , 2012, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[27]  K. Oktay,et al.  Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Li'na Hu,et al.  Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women. , 2011, The Cochrane database of systematic reviews.

[29]  R. Tamimi,et al.  Prospective study of fertility concerns and preservation strategies in young women with breast cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  Claus Yding Andersen,et al.  Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. , 2013, Fertility and sterility.

[31]  L. Fallowfield,et al.  The OPTION trial of adjuvant ovarian protection by goserelin in adjuvant chemotherapy for early breast cancer. , 2010 .

[32]  D. Merlo,et al.  Is Letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer? , 2013, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[33]  R. Farrell,et al.  Protecting Ovaries During Chemotherapy Through Gonad Suppression: A Systematic Review and Meta-analysis. , 2015, Obstetrics and gynecology.

[34]  M. Piccart,et al.  Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  Zhixian Yuan,et al.  Effect of leuprolide acetate on ovarian function after cyclophosphamide–doxorubicin-based chemotherapy in premenopausal patients with breast cancer: results from a phase II randomized trial , 2013, Medical Oncology.

[36]  M. Cedars,et al.  Effective method for emergency fertility preservation: random-start controlled ovarian stimulation. , 2012, Fertility and sterility.

[37]  H. Gómez,et al.  Attitudes of young patients with breast cancer toward fertility loss related to adjuvant systemic therapies. EORTC study 10002 BIG 3‐98 , 2014, Psycho-oncology.

[38]  M. Beckmann,et al.  Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation. , 2012, Fertility and sterility.

[39]  T. Strowitzki,et al.  Fertility preservation in >1,000 patients: patient’s characteristics, spectrum, efficacy and risks of applied preservation techniques , 2011, Archives of Gynecology and Obstetrics.

[40]  John D Boice,et al.  Congenital anomalies in the children of cancer survivors: a report from the childhood cancer survivor study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  D. Meirow,et al.  Luteal phase oocyte retrieval and in vitro maturation is an optional procedure for urgent fertility preservation. , 2011, Fertility and sterility.

[42]  L. Brinton,et al.  Long-term Relationship of Ovulation-Stimulating Drugs to Breast Cancer Risk , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[43]  W. Willett,et al.  Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II , 2013, Breast Cancer Research.

[44]  M. Beckmann,et al.  Pregnancies and live births after 20 transplantations of cryopreserved ovarian tissue in a single center. , 2015, Fertility and Sterility.

[45]  D. Lamb,et al.  Cancer risk among children born after assisted conception. , 2014, The New England journal of medicine.

[46]  F. V. van Leeuwen,et al.  Autotransplantation of cryopreserved ovarian tissue in cancer survivors and the risk of reintroducing malignancy: a systematic review. , 2013, Human reproduction update.

[47]  H. Critchley,et al.  Impact of cancer treatment on uterine function. , 2005, Journal of the National Cancer Institute. Monographs.

[48]  T. Tulandi,et al.  Assisted reproductive outcomes of male cancer survivors , 2015, Journal of Cancer Survivorship.

[49]  P. Katz,et al.  Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer , 2012, Cancer.

[50]  P. Patrizio,et al.  American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  W. Wallace,et al.  The radiosensitivity of the human oocyte. , 2003, Human reproduction.

[52]  M. Andersen,et al.  Cryopreserved ovarian cortex from patients with leukemia in complete remission contains no apparent viable malignant cells. , 2012, Blood.

[53]  L. Boni,et al.  Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical Trial. , 2015, JAMA.

[54]  D. Meirow,et al.  Ovarian tissue cryopreservation and transplantation: a realistic, effective technology for fertility preservation. , 2014, Methods in molecular biology.

[55]  G. Bedoschi,et al.  Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  S. Báo,et al.  Effects of lowered temperatures and media on short-term preservation of zebu (Bos indicus) preantral ovarian follicles. , 2004, Theriogenology.

[57]  E. Elgindy,et al.  Protecting Ovaries During Chemotherapy Through Gonad Suppression: A Systematic Review and Meta-analysis , 2015, Obstetrics and gynecology.

[58]  H. Yarali,et al.  Best Protocol for Controlled Ovarian Hyperstimulation in Assisted Reproductive Technologies: Fact or Opinion? , 2014, Seminars in Reproductive Medicine.

[59]  Yu Shyr,et al.  Genetic disease in the children of Danish survivors of childhood and adolescent cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[60]  D. Spiegelman,et al.  Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. , 2006, Journal of the National Cancer Institute.

[61]  A. Veiga,et al.  How does vitrification affect oocyte viability in oocyte donation cycles? A prospective study to compare outcomes achieved with fresh versus vitrified sibling oocytes. , 2013, Human reproduction.

[62]  L. Schover,et al.  The psychosocial impact of interrupted childbearing in long‐term female cancer survivors , 2012, Psycho-oncology.

[63]  B. Pistilli,et al.  Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcome. , 2015, European journal of cancer.

[64]  Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. , 1997, Lancet.

[65]  M. Höglund,et al.  Sex differences in fertility-related information received by young adult cancer survivors. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[66]  R. Chian,et al.  Fertility Preservation with Immature and in Vitro Matured Oocytes , 2009, Seminars in reproductive medicine.

[67]  R. Gelber,et al.  Pregnancy after breast cancer: Are young patients willing to participate in clinical studies? , 2015, Breast.

[68]  Xiao-yan Li,et al.  Concurrent treatment with gonadotropin-releasing hormone agonists for chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a meta-analysis of randomized controlled trials. , 2013, Breast.

[69]  A. Agarwal,et al.  Disruption of spermatogenesis by the cancer disease process. , 2005, Journal of the National Cancer Institute. Monographs.

[70]  G. Bedoschi,et al.  Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients. , 2013, Fertility and sterility.

[71]  I. Ben-Aharon,et al.  Doxorubicin-induced apoptosis in germinal vesicle (GV) oocytes. , 2010, Reproductive toxicology.

[72]  S. Paluch-Shimon,et al.  Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies. , 2014, Fertility and sterility.

[73]  M. van Wely,et al.  Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology. , 2014, The Cochrane database of systematic reviews.

[74]  H. Bang,et al.  Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. , 2006, The Journal of clinical endocrinology and metabolism.

[75]  A. Partridge,et al.  Update on fertility preservation in young women undergoing breast cancer and ovarian cancer therapy , 2015, Current opinion in obstetrics & gynecology.

[76]  P. Bruzzi,et al.  Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials. , 2014, Cancer treatment reviews.

[77]  S. Loibl,et al.  Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01-01) , 2012, Breast Cancer Research and Treatment.

[78]  R. Gelber,et al.  Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[79]  J. Donnez,et al.  Transplantation of ovarian tissue. , 2014, Best practice & research. Clinical obstetrics & gynaecology.

[80]  M. Alfò,et al.  Impact of different treatment approaches on pregnancy outcomes in 99 women treated for Hodgkin lymphoma. , 2012, International journal of radiation oncology, biology, physics.

[81]  D. Gook,et al.  Human oocyte cryopreservation. , 2007, Human reproduction update.

[82]  J. Forbes,et al.  Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. , 2015, The New England journal of medicine.

[83]  Daniel H. Williams,et al.  Sperm banking and the cancer patient , 2010, Therapeutic advances in urology.

[84]  L. Kjeldsen,et al.  Evidence of residual disease in cryopreserved ovarian cortex from female patients with leukemia. , 2010, Fertility and sterility.

[85]  M. Sormani,et al.  Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies , 2015, Breast Cancer Research and Treatment.

[86]  J. Semmens,et al.  Pregnancy after breast cancer: population based study , 2006, BMJ : British Medical Journal.

[87]  M. El-ashry,et al.  Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. , 2009, Fertility and sterility.

[88]  L. Rienzi,et al.  Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentric study. , 2012, Human reproduction.

[89]  L. Holmberg,et al.  Birth Outcome in Women with Previously Treated Breast Cancer—A Population-Based Cohort Study from Sweden , 2006, PLoS medicine.

[90]  G. Bedoschi,et al.  Ovarian stimulation during the luteal phase for fertility preservation of cancer patients: case reports and review of the literature , 2010, Journal of Assisted Reproduction and Genetics.

[91]  T. Fehm,et al.  Pregnancy after Successful Cancer Treatment: What Needs to Be Considered? , 2012, Oncology Research and Treatment.

[92]  Gary D. Smith,et al.  Prospective randomized comparison of human oocyte cryopreservation with slow-rate freezing or vitrification. , 2010, Fertility and sterility.

[93]  Lindsey M. King,et al.  Discussion of fertility preservation with newly diagnosed patients: oncologists’ views , 2007, Journal of cancer survivorship : research and practice.

[94]  G. Dohle Male infertility in cancer patients: Review of the literature , 2010, International journal of urology : official journal of the Japanese Urological Association.

[95]  C. Andersen Success and challenges in fertility preservation after ovarian tissue grafting , 2015, The Lancet.

[96]  L. Leibovici,et al.  Pharmacological interventions for fertility preservation during chemotherapy: a systematic review and meta-analysis , 2010, Breast Cancer Research and Treatment.

[97]  V. Diehl,et al.  Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[98]  C. Anders,et al.  Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis. , 2009, Journal of women's health.

[99]  H. Wasvary,et al.  Multidisciplinary management of colorectal cancer enhances access to multimodal therapy and compliance with National Comprehensive Cancer Network (NCCN) guidelines , 2012, International Journal of Colorectal Disease.

[100]  Y. Friedlander,et al.  Cancer risk after exposure to treatments for ovulation induction. , 2008, American journal of epidemiology.

[101]  R. Anderson,et al.  Long term follow-up of survivors of childhood cancer: summary of updated SIGN guidance , 2013, BMJ.

[102]  E. Winer,et al.  Web-based survey of fertility issues in young women with breast cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[103]  M. Chung,et al.  Long-term ovarian function and fertility after heterotopic autotransplantation of cryobanked human ovarian tissue: 8-year experience in cancer patients. , 2009, Fertility and sterility.

[104]  N. Pavlidis,et al.  Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[105]  O. Khorshid,et al.  Gonadatrophin Suppression to Prevent Chemotherapy-Induced Ovarian Damage: A Randomized Controlled Trial , 2013, Obstetrics and gynecology.

[106]  A. Goldhirsch,et al.  Timing of adjuvant systemic therapy and radiotherapy after breast-conserving surgery and mastectomy. , 2010, Cancer treatment reviews.

[107]  K. Oktay,et al.  Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[108]  M. Rosen,et al.  Ovarian stimulation in cancer patients. , 2013, Fertility and sterility.

[109]  F. Fu,et al.  Gonadotropin-Releasing Hormone Analog Cotreatment for the Preservation of Ovarian Function during Gonadotoxic Chemotherapy for Breast Cancer: A Meta-Analysis , 2013, PloS one.

[110]  T. Strowitzki,et al.  Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. , 2009, Fertility and sterility.

[111]  A. Rosen,et al.  Psychosocial distress in young cancer survivors. , 2009, Seminars in oncology nursing.

[112]  A. Veiga,et al.  Live birth using vitrified--warmed oocytes in invasive ovarian cancer: case report and literature review. , 2014, Reproductive biomedicine online.

[113]  L. Boni,et al.  Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. , 2011, JAMA.

[114]  A. Pellicer,et al.  Fertility preservation for age-related fertility decline , 2015, The Lancet.

[115]  B. Källén,et al.  Malignancies among women who gave birth after in vitro fertilization. , 2011, Human reproduction.

[116]  S. Fosså,et al.  Pregnancy after adolescent and adult cancer: A population‐based matched cohort study , 2011, International journal of cancer.

[117]  S. Missmer,et al.  Relationship between reproductive history, anthropometrics, lifestyle factors, and the likelihood of persistent chemotherapy-related amenorrhea in women with premenopausal breast cancer. , 2012, Fertility and sterility.

[118]  A. Pellicer,et al.  Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment. , 2012, Fertility and sterility.

[119]  K. Oktay Evidence for limiting ovarian tissue harvesting for the purpose of transplantation to women younger than 40 years of age. , 2002, The Journal of clinical endocrinology and metabolism.

[120]  Kendra Johnson,et al.  Integration of and adherence to National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines) in a Community Cancer Center , 2015 .

[121]  P. Munster,et al.  Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[122]  K. Oktay,et al.  Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[123]  W. Wallace,et al.  Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservation , 2014, The Lancet. Oncology.

[124]  D. Keefe,et al.  Fertility in women with BRCA mutations: a case-control study. , 2010, Fertility and sterility.

[125]  A. Loft,et al.  Treatment history and outcome of 24 deliveries worldwide after autotransplantation of cryopreserved ovarian tissue, including two new Danish deliveries years after autotransplantation , 2014, Journal of Assisted Reproduction and Genetics.

[126]  H. Kanety,et al.  Cyclophosphamide Triggers Follicle Activation and “Burnout”; AS101 Prevents Follicle Loss and Preserves Fertility , 2013, Science Translational Medicine.

[127]  Julian Peto,et al.  Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer , 1997, The Lancet.

[128]  K. Diedrich,et al.  Initiation of ovarian stimulation independent of the menstrual cycle: a case–control study , 2013, Archives of Gynecology and Obstetrics.

[129]  U. Keskin,et al.  Random-start controlled ovarian hyperstimulation with letrozole for fertility preservation in cancer patients: case series and review of literature. , 2014, JPMA. The Journal of the Pakistan Medical Association.

[130]  T. Key,et al.  Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. , 2002, Journal of the National Cancer Institute.

[131]  M. Hasanzadeh,et al.  Ovarian preservation with gonadotropin‐releasing hormone analog during chemotherapy , 2007 .

[132]  V. Diehl,et al.  No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[133]  Richard A. Anderson,et al.  Fertility preservation for young patients with cancer: who is at risk and what can be offered? , 2005, The Lancet. Oncology.

[134]  F. Amant,et al.  Strategies for fertility preservation in young early breast cancer patients. , 2014, Breast.

[135]  B. Kong,et al.  Protection of ovarian function by GnRH agonists during chemotherapy: a meta-analysis. , 2014, International journal of oncology.

[136]  S. Loibl,et al.  Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[137]  N. Michaan,et al.  Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients. , 2010, European journal of obstetrics, gynecology, and reproductive biology.

[138]  W. Wallace,et al.  Safety considerations for transplanting cryopreserved ovarian tissue to restore fertility in female patients who have recovered from Ewing's sarcoma. , 2014, Future oncology.

[139]  Z. Rosenwaks,et al.  Successful treatment of postchemotherapy azoospermia with microsurgical testicular sperm extraction: the Weill Cornell experience. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[140]  S. Nayak,et al.  Random-start gonadotropin-releasing hormone (GnRH) antagonist-treated cycles with GnRH agonist trigger for fertility preservation. , 2011, Fertility and sterility.

[141]  K. Rothman,et al.  Birth outcome in women with breast cancer , 2005, British Journal of Cancer.

[142]  L. Westphal,et al.  Ovarian stimulation for fertility preservation in patients with cancer. , 2010, Fertility and sterility.

[143]  P. Patrizio,et al.  Sperm cryopreservation for male patients with cancer: an epidemiological analysis at the University of Pennsylvania. , 2003, European journal of obstetrics, gynecology, and reproductive biology.

[144]  S. Tough,et al.  Delayed child-bearing. , 2012, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[145]  M. Clark,et al.  Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[146]  Peng Li,et al.  Fertility outcome of patients with testicular tumor: Before and after treatment , 2013, Asian journal of andrology.

[147]  A. Nyboe Andersen,et al.  Survival of primordial follicles following prolonged transportation of ovarian tissue prior to cryopreservation. , 2003, Human reproduction.

[148]  C. Fung,et al.  Gonadotropin-releasing hormone agonists for the preservation of ovarian function among women with breast cancer who did not use tamoxifen after chemotherapy: a systematic review and meta-analysis. , 2014, Fertility and sterility.

[149]  E. Porcu,et al.  Multicenter observational study on slow-cooling oocyte cryopreservation: clinical outcome. , 2010, Fertility and sterility.

[150]  A. Ciapponi,et al.  Vitrification versus slow freezing for women undergoing oocyte cryopreservation. , 2014, The Cochrane database of systematic reviews.

[151]  A. Borini,et al.  Oocyte slow freezing using a 0.2-0.3 M sucrose concentration protocol: is it really the time to trash the cryopreservation machine? , 2012, Fertility and sterility.

[152]  E. Ernst,et al.  Long-term duration of function of ovarian tissue transplants: case reports. , 2012, Reproductive biomedicine online.